← Back to feed Brand & Business

Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?

Quartz 14 April 2026 15h ago
Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?
59
Relevance
9/25
Freshness
24/25
Authority
18/20
Brand Signal
6/15
Depth
2/15
Relevance Freshness Authority Brand Depth
ABBV eyes a strong Q1 performance as neuroscience sales, led by Botox and Vraylar, are set to jump 22%, with newer drugs helping offset declines in legacy treat
Read Full Article → Quartz ↗